Comparative analysis of expression of the proprotein convertases furin, PACE4, PCI and PC2 in human lung tumours
1997

Expression of Proprotein Convertases in Human Lung Tumours

Sample size: 48 publication Evidence: moderate

Author Information

Author(s): M Mbikay, F Sirois, J Yao, NG Seidah, M Chr6tien

Primary Institution: Institut de Recherches Cliniques de Montréal, Université de Montréal

Hypothesis

The study hypothesizes that proprotein convertases may contribute to the unchecked proliferation of cancer cells by mediating the production of peptidic mitogens.

Conclusion

The study found that small-cell lung carcinomas often have higher levels of PC1 and PC2 mRNA and lower levels of furin and PACE4 mRNA compared to other lung cancer types.

Supporting Evidence

  • Furin mRNA was expressed in all tumors, with higher levels in squamous cell carcinomas and adenocarcinomas compared to small-cell lung carcinomas.
  • PACE4 transcripts were detected in a subset of adenocarcinomas and squamous cell carcinomas but were rare in small-cell lung carcinomas.
  • PC1 mRNA was undetected in squamous cell carcinomas and most adenocarcinomas but present in some small-cell lung carcinomas.
  • PC2 mRNA was found in a few adenocarcinomas and more frequently in small-cell lung carcinomas.

Takeaway

Researchers looked at lung cancer samples to see how certain proteins are made, finding that some types of lung cancer make different amounts of these proteins.

Methodology

The study used semiquantitative Northern blot analysis to examine mRNA levels of four convertases in lung tumor samples.

Limitations

The study is preliminary and needs to be extended to a larger panel of lung tumors for stronger correlations.

Participant Demographics

The study included 48 surgical lung tumor samples from various histological types.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication